Literature DB >> 34709640

Isolation and Identification of Dengue Virus Interactome with Human Plasma Proteins by Affinity Purification-Mass Spectrometry.

Vivian Huerta1, Yassel Ramos2.   

Abstract

Viral proteins evolve to benefit the interaction with host proteins during the infection and replication processes. A comprehensive understanding of virus interactome with host proteins may thus lead to the identification of molecular targets for infection inhibition. We present a procedure for isolating and identifying the dengue virus interactome with human plasma proteins. It comprises the fractionation of human plasma by anion exchange chromatography, followed by affinity purification and mass spectrometry identification of the captured proteins. This procedure was applied to the characterization of the interactions of the four serotypes of dengue virus with human plasma proteins, mediated by the domain III of the envelope protein of the virus. The resulting interactome comprises 62 proteins, six of which were validated as new direct interactions of the virus with its human host.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Binding; Chromatography; Dengue virus; Fractionation; Human plasma

Mesh:

Substances:

Year:  2022        PMID: 34709640     DOI: 10.1007/978-1-0716-1879-0_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  49 in total

1.  Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors.

Authors:  Suchita Bhattacharyya; Anna Zagórska; Erin D Lew; Bimmi Shrestha; Carla V Rothlin; John Naughton; Michael S Diamond; Greg Lemke; John A T Young
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

2.  The effect of stimulus strength on the jaw-jerk response in man.

Authors:  G R Lewis; R Pilcher; R Yemm
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-08       Impact factor: 10.154

3.  Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity.

Authors:  Naphak Modhiran; Daniel Watterson; David A Muller; Adele K Panetta; David P Sester; Lidong Liu; David A Hume; Katryn J Stacey; Paul R Young
Journal:  Sci Transl Med       Date:  2015-09-09       Impact factor: 17.956

4.  Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination.

Authors:  P Robert Beatty; Henry Puerta-Guardo; Sarah S Killingbeck; Dustin R Glasner; Kaycie Hopkins; Eva Harris
Journal:  Sci Transl Med       Date:  2015-09-09       Impact factor: 17.956

Review 5.  Innate immunity to dengue virus infection and subversion of antiviral responses.

Authors:  Angela M Green; P Robert Beatty; Alexandros Hadjilaou; Eva Harris
Journal:  J Mol Biol       Date:  2013-12-03       Impact factor: 5.469

Review 6.  Subversion of cytokine networks by virally encoded decoy receptors.

Authors:  Megan L Epperson; Chung A Lee; Daved H Fremont
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

7.  The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry.

Authors:  Laurent Meertens; Xavier Carnec; Manuel Perera Lecoin; Rasika Ramdasi; Florence Guivel-Benhassine; Erin Lew; Greg Lemke; Olivier Schwartz; Ali Amara
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

8.  Virus-host interactomics: new insights and opportunities for antiviral drug discovery.

Authors:  Benoît de Chassey; Laurène Meyniel-Schicklin; Jacky Vonderscher; Patrice André; Vincent Lotteau
Journal:  Genome Med       Date:  2014-11-29       Impact factor: 11.117

9.  Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability.

Authors:  Henry Puerta-Guardo; Dustin R Glasner; Eva Harris
Journal:  PLoS Pathog       Date:  2016-07-14       Impact factor: 6.823

10.  Human apolipoprotein A-I is associated with dengue virus and enhances virus infection through SR-BI.

Authors:  Yujia Li; Cherie Kakinami; Qi Li; Baojun Yang; Hongwei Li
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.